“The Association Between Immune-Histochemical Expressions of Program Death Ligand With Some Aggressive Features of Prostate Cancer”. Al-Nahrain Journal of Science, vol. 27, no. 2, June 2024, pp. 63-67, https://doi.org/10.22401/g18c0m59.